CAS 1618644-32-8
:Alogliptin benzoate impurity K
Description:
Alogliptin benzoate impurity K, with the CAS number 1618644-32-8, is a chemical compound that serves as an impurity associated with the pharmaceutical agent alogliptin benzoate, which is used in the treatment of type 2 diabetes. This impurity is characterized by its specific molecular structure, which includes functional groups that may influence its solubility, stability, and reactivity. Typically, impurities like this are monitored during the synthesis and formulation of pharmaceuticals to ensure product quality and safety. The presence of such impurities can affect the pharmacokinetics and pharmacodynamics of the primary drug, making it essential to quantify and characterize them during drug development. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and measure impurities in pharmaceutical products. Understanding the characteristics of impurities like alogliptin benzoate impurity K is crucial for regulatory compliance and ensuring the efficacy and safety of the final medicinal product.
Formula:C25H25N5O3
Synonyms:- alogliptina impurity 4
- (S)-N-(1-(3-(2-Cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)benzamide
- (R)-N-(1-(3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)benzamide
- Benzamide, N-[(3S)-1-[3-[(2-cyanophenyl)methyl]-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]-3-piperidinyl]-
- Alogliptin-8
- Alogliptin impurity 11/(R)-N-(1-(3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)benzamide
- alogliptin impurities154
- alogliptin impurities7
- Alogliptin benzoate impurity K
- (R)-N-(1-(3-(2-cyanobenzyl)-1-methyl
- Alogliptin Impurity-11 (6- Drotaverine)
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.
